Analysis of cell cycle regulator proteins in non-small cell lung cancer (Q35587286)

9 August 2017

title

Analysis of cell cycle regulator proteins in non-small cell lung cancer (English)

1 reference

9 August 2017

1 reference

Esposito V

1

1 reference

9 August 2017

Baldi A

2

1 reference

9 August 2017

Tonini G

3

1 reference

9 August 2017

Vincenzi B

4

1 reference

9 August 2017

Santini M

5

1 reference

9 August 2017

Ambrogi V

6

1 reference

9 August 2017

Mineo TC

7

1 reference

9 August 2017

Persichetti P

8

1 reference

9 August 2017

Liuzzi G

9

1 reference

9 August 2017

Montesarchio V

10

1 reference

9 August 2017

Wolner E

11

1 reference

9 August 2017

Baldi F

12

1 reference

9 August 2017

Groeger AM

13

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Journal of Clinical Pathology

9 August 2017

published in

1 reference

9 August 2017

volume

57

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

58-63

1 reference

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Recent trends in lung cancer mortality in the United States

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

27 July 2018

Cancer statistics, 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Revisions in the International System for Staging Lung Cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

p21waf1/cip1mda-6 expression in non-small-cell lung cancer: relationship to survival.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770176

Prognostic impact of p21/waf1/cip1 in colorectal cancer

15 November 2018

1 reference

12 December 2020

Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.

1 reference

12 December 2020

Molecular Pathogenesis of Lung Cancer

1 reference

12 December 2020

Clinical significance of p21 expression in non-small-cell lung cancer

1 reference

12 December 2020

Tumor-suppressor p53: implications for tumor development and prognosis

1 reference

12 December 2020

Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers

1 reference

12 December 2020

Independent prognostic role of p16 expression in lung cancer

1 reference

12 December 2020

p53 and PCNA expression in advanced colorectal cancer: response to chemotherapy and long-term prognosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.57.1.58

1 reference

9 August 2017

1 reference

9 August 2017

1 reference